ITRM930286A0 - Composizione farmaceutica per somministrazione rettale nel trattamentodi cefaleo e relativo metodo di preparazione ed impiego. - Google Patents

Composizione farmaceutica per somministrazione rettale nel trattamentodi cefaleo e relativo metodo di preparazione ed impiego.

Info

Publication number
ITRM930286A0
ITRM930286A0 IT93RM286A ITRM930286A ITRM930286A0 IT RM930286 A0 ITRM930286 A0 IT RM930286A0 IT 93RM286 A IT93RM286 A IT 93RM286A IT RM930286 A ITRM930286 A IT RM930286A IT RM930286 A0 ITRM930286 A0 IT RM930286A0
Authority
IT
Italy
Prior art keywords
headache
preparation
treatment
pharmaceutical composition
rectal administration
Prior art date
Application number
IT93RM286A
Other languages
English (en)
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of ITRM930286A0 publication Critical patent/ITRM930286A0/it
Publication of ITRM930286A1 publication Critical patent/ITRM930286A1/it
Application granted granted Critical
Publication of IT1261471B publication Critical patent/IT1261471B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
ITRM930286A 1992-05-07 1993-05-06 Composizione farmaceutica per somministrazione rettale nel trattamentodi cefalea e relativo metodo di preparazione ed impiego. IT1261471B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions

Publications (3)

Publication Number Publication Date
ITRM930286A0 true ITRM930286A0 (it) 1993-05-06
ITRM930286A1 ITRM930286A1 (it) 1994-11-06
IT1261471B IT1261471B (it) 1996-05-23

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM930286A IT1261471B (it) 1992-05-07 1993-05-06 Composizione farmaceutica per somministrazione rettale nel trattamentodi cefalea e relativo metodo di preparazione ed impiego.

Country Status (33)

Country Link
US (1) US5705506A (it)
EP (1) EP0639072B1 (it)
JP (1) JPH07506570A (it)
KR (1) KR100253111B1 (it)
AT (1) ATE163850T1 (it)
AU (1) AU670083B2 (it)
BE (1) BE1007024A5 (it)
BG (1) BG62120B1 (it)
BR (1) BR1100108A (it)
CA (1) CA2135179C (it)
CH (1) CH685920A5 (it)
CY (1) CY2039B1 (it)
CZ (1) CZ283512B6 (it)
DE (1) DE69317418T2 (it)
ES (1) ES2113533T3 (it)
FR (1) FR2690847B1 (it)
GB (2) GB9209882D0 (it)
GR (1) GR3026584T3 (it)
HK (1) HK95697A (it)
HU (2) HU227338B1 (it)
IE (1) IE75203B1 (it)
IL (1) IL105468A (it)
IT (1) IT1261471B (it)
NO (1) NO306700B1 (it)
NZ (1) NZ252132A (it)
OA (1) OA10109A (it)
RO (1) RO112993B1 (it)
RU (1) RU2118527C1 (it)
SG (1) SG46649A1 (it)
TW (1) TW231970B (it)
UA (1) UA37206C2 (it)
WO (1) WO1993021916A1 (it)
ZA (1) ZA933178B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044062A1 (en) * 1996-05-23 1997-11-27 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
PT2198858E (pt) * 1998-03-26 2011-09-01 Astellas Pharma Inc Composição farmacêutica de libertação constante que contém um macrólido como o tacrolimus
AU3731400A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
AR056690A1 (es) * 2005-10-14 2007-10-17 Athersys Inc Derivados de indol como inhibidores de indol como inhibidores del receptor 3 de histamina para el tartamiento de trastornos del sueno y cognitivos obesidad y otros trastornos de snc
JP2010522135A (ja) 2006-10-09 2010-07-01 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
JP5714910B2 (ja) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド 薬学的組成物
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
KR101825972B1 (ko) 2010-10-15 2018-02-06 콘테라 파르마 에이피에스 운동 장애 치료를 위한 세로토닌 수용체 작용제의 조합
PT2838517T (pt) 2012-04-18 2018-01-04 Contera Pharma Aps Formulação farmacêutica disponível sob forma oral adequada para a melhoria da gestão dos distúrbios da mobilidade
JP2019507181A (ja) 2016-03-04 2019-03-14 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
CA3030089C (en) 2016-07-11 2024-04-23 Contera Pharma Aps Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1171450B (it) * 1980-08-12 1987-06-10 Glaxo Group Ltd Composti eterociclici indolici, procedimento per produrli e composizioni farmaceutiche che li contengono
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
HU196752B (en) * 1983-12-06 1989-01-30 Glaxo Group Ltd Process for production of medical compositions containing indole-derivatives and these compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
IT1181741B (it) * 1984-12-04 1987-09-30 Glaxo Group Ltd Derivati di indolo,procedimento per prepararli e composizioni farmaceutiche che li contengono
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
US4833153A (en) * 1985-11-08 1989-05-23 Glaxo Group Limited Indole derivatives
DK172696B1 (da) * 1987-08-13 1999-05-31 Glaxo Group Ltd Indolderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende forbindelserne
KR100215627B1 (ko) * 1990-06-07 1999-08-16 레슬리 제인 에드워즈 치료용 헤테로사이클 화합물

Also Published As

Publication number Publication date
ATE163850T1 (de) 1998-03-15
SG46649A1 (en) 1998-02-20
CY2039B1 (en) 1998-04-30
HU227338B1 (en) 2011-04-28
CA2135179A1 (en) 1993-11-11
IE75203B1 (en) 1997-08-27
NO944214L (no) 1994-11-07
AU4064093A (en) 1993-11-29
ES2113533T3 (es) 1998-05-01
NO944214D0 (no) 1994-11-04
IL105468A0 (en) 1993-08-18
GB9209882D0 (en) 1992-06-24
OA10109A (en) 1996-12-18
DE69317418D1 (de) 1998-04-16
CA2135179C (en) 2000-12-05
GR3026584T3 (en) 1998-07-31
WO1993021916A1 (en) 1993-11-11
UA37206C2 (uk) 2001-05-15
US5705506A (en) 1998-01-06
HK95697A (en) 1997-08-08
JPH07506570A (ja) 1995-07-20
BE1007024A5 (fr) 1995-02-21
AU670083B2 (en) 1996-07-04
FR2690847A1 (fr) 1993-11-12
DE69317418T2 (de) 1998-07-30
BG99167A (bg) 1995-06-30
EP0639072A1 (en) 1995-02-22
RO112993B1 (ro) 1998-03-30
KR100253111B1 (en) 2000-07-01
NO306700B1 (no) 1999-12-13
EP0639072B1 (en) 1998-03-11
GB2266665A (en) 1993-11-10
IT1261471B (it) 1996-05-23
BR1100108A (pt) 1999-12-07
FR2690847B1 (fr) 1995-06-09
HU211638A9 (en) 1995-12-28
IE930339A1 (en) 1993-11-17
TW231970B (it) 1994-10-11
IL105468A (en) 1998-09-24
ITRM930286A1 (it) 1994-11-06
HUT71418A (en) 1995-11-28
CZ283512B6 (cs) 1998-04-15
RU2118527C1 (ru) 1998-09-10
BG62120B1 (bg) 1999-03-31
GB9309209D0 (en) 1993-06-16
CZ272394A3 (en) 1995-10-18
CH685920A5 (fr) 1995-11-15
NZ252132A (en) 1996-09-25
GB2266665B (en) 1996-05-22
ZA933178B (en) 1994-01-10

Similar Documents

Publication Publication Date Title
FI923548A7 (fi) Vaahtoa muodostava koostumus farmaseuttiseen käyttöön, sen käyttö ja h oitomenetelmä
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
ITBO910476A0 (it) -formulazioni farmeceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali.
EE9900075A (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
MX9202436A (es) Composiciones para el cuidado del cabello y metodo para su preparacion.
DE3689384D1 (de) Arzneimittel zur topischen Anwendung.
FI903845A7 (fi) Reniini-inhibiittoreita, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeissä
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
FI952230L (fi) Uusi aryylipropaanijohdannainen, menetelmä sen valmistamiseksi ja sen käyttö analgeettisena aineena
FI915970A7 (fi) Lääkkeitä, jotka ovat hyödyllisiä syövän hoidossa ja joilla on antihis tamiiniominaisuuksia
FI863971A7 (fi) Farmaseuttinen koostumus käytettäväksi leukopenian hoidossa.
FI945975A7 (fi) Haarautuneella aminoryhmällä substituoituja tiatsoleja, menetelmiä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
FI963883L (fi) Farmaseuttisia valmisteita ja lääkeaineita endoteelin toimintahäiriön ehkäisemiseksi ja hoitamiseksi
NL193217B (nl) 1-Methyl-5-p-toluoyl-2-pyrroolaceetamidederivaat met ontstekingsremmende en analgetische eigenschappen en farmaceutisch preparaat dat het bevat.
ITRM910002A0 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
BR9302389A (pt) Composto,formulacao farmaceutica e processo para preparar o composto
IT8468281A1 (it) Proglumide e composizioni farmaceutiche che la contengono per l'impiego nella terapia di affezioni neoplastiche.
IT7925706A0 (it) Uso di glicerilfosforilderivati nella terapia di dislipemie ed epatiti, e composizioni farmaceutiche relative.
FI956353L (fi) Farmaseuttiset valmisteet ja niiden käyttö etenkin neurodegeneratiivisten sairauksien hoidossa
IT1190042B (it) Alchil o aralchil tio-2 cicloalchene 1 carbossammidi 1 e loro solfossidi,procedimenti per la loro preparazione e loro applicazione nella sintesi di tri e tetrametilen-4,5 isotiazolin-4 oni-3
IT8519907A0 (it) Prodotto farmaceutico cosmetico, in particolare per la cura di acne e seborrea.
BR9610851A (pt) Composto processo de preparação de composto medicamento composição farmacêuticas e utilização do composto
ITRM920305A0 (it) Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.
ITRM910963A0 (it) Composizione farmaceutica effervescente anticefalalgica e metodo per prepararla ed applicarla.
IT8219012A0 (it) Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970530